Production (Stage)
Semler Scientific, Inc.
SMLR
$41.32
-$2.07-4.77%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -25.28% | -17.44% | -11.93% | -4.50% | 8.22% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -25.28% | -17.44% | -11.93% | -4.50% | 8.22% |
| Cost of Revenue | -0.80% | 5.59% | -4.48% | -5.95% | -1.45% |
| Gross Profit | -27.07% | -19.07% | -12.51% | -4.39% | 9.00% |
| SG&A Expenses | -9.11% | -20.43% | -16.69% | -13.68% | -4.97% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.75% | -17.22% | -15.26% | -13.33% | -4.02% |
| Operating Income | -51.86% | -17.80% | -5.96% | 13.18% | 34.17% |
| Income Before Tax | -237.66% | 98.68% | -28.21% | -18.03% | 23.96% |
| Income Tax Expenses | -237.09% | 98.58% | -61.01% | -43.01% | -19.56% |
| Earnings from Continuing Operations | -237.76% | 98.70% | -18.71% | -10.82% | 36.11% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -237.76% | 98.70% | -18.71% | -10.82% | 36.11% |
| EBIT | -51.86% | -17.80% | -5.96% | 13.18% | 34.17% |
| EBITDA | -51.71% | -17.94% | -6.07% | 12.69% | 32.18% |
| EPS Basic | -172.20% | 73.72% | -21.25% | -12.27% | 34.69% |
| Normalized Basic EPS | -88.14% | 50.10% | -21.74% | -5.21% | 40.15% |
| EPS Diluted | -193.77% | 87.09% | -18.39% | -9.77% | 38.27% |
| Normalized Diluted EPS | -95.83% | 61.23% | -18.23% | -2.15% | 44.12% |
| Average Basic Shares Outstanding | 16.58% | 7.37% | 3.25% | 2.17% | 1.08% |
| Average Diluted Shares Outstanding | 8.10% | 1.92% | -1.32% | -1.55% | -1.83% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |